nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisinopril—ACE—osteoporosis	0.623	1	CbGaD
Lisinopril—ABCB1—Ethinyl Estradiol—osteoporosis	0.0151	0.42	CbGbCtD
Lisinopril—ACE2—Metabolism of Angiotensinogen to Angiotensins—REN—osteoporosis	0.012	0.156	CbGpPWpGaD
Lisinopril—ACE2—ACE Inhibitor Pathway—REN—osteoporosis	0.0115	0.149	CbGpPWpGaD
Lisinopril—ABCB1—Conjugated Estrogens—osteoporosis	0.0111	0.309	CbGbCtD
Lisinopril—ABCB1—Estradiol—osteoporosis	0.00971	0.271	CbGbCtD
Lisinopril—ACE2—Metabolism of Angiotensinogen to Angiotensins—ACE—osteoporosis	0.00751	0.0976	CbGpPWpGaD
Lisinopril—ACE2—ACE Inhibitor Pathway—ACE—osteoporosis	0.00716	0.093	CbGpPWpGaD
Lisinopril—ACE—Metabolism of Angiotensinogen to Angiotensins—REN—osteoporosis	0.00538	0.0699	CbGpPWpGaD
Lisinopril—ACE—ACE Inhibitor Pathway—REN—osteoporosis	0.00512	0.0665	CbGpPWpGaD
Lisinopril—ACE2—Peptide hormone metabolism—REN—osteoporosis	0.00316	0.0411	CbGpPWpGaD
Lisinopril—ABCB1—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00304	0.0395	CbGpPWpGaD
Lisinopril—ACE2—ACE Inhibitor Pathway—TGFB1—osteoporosis	0.0022	0.0286	CbGpPWpGaD
Lisinopril—ACE2—Peptide hormone metabolism—ACE—osteoporosis	0.00198	0.0257	CbGpPWpGaD
Lisinopril—ACE—Peptide hormone metabolism—REN—osteoporosis	0.00141	0.0184	CbGpPWpGaD
Lisinopril—ACE2—Peptide hormone metabolism—LEP—osteoporosis	0.00123	0.0159	CbGpPWpGaD
Lisinopril—ACE2—Peptide hormone metabolism—POMC—osteoporosis	0.00105	0.0137	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—CCT2—osteoporosis	0.00104	0.0135	CbGpPWpGaD
Lisinopril—ACE2—Peptide hormone metabolism—IGF1—osteoporosis	0.00101	0.0132	CbGpPWpGaD
Lisinopril—ACE—ACE Inhibitor Pathway—TGFB1—osteoporosis	0.000984	0.0128	CbGpPWpGaD
Lisinopril—Fosinopril—ACE—osteoporosis	0.000885	0.136	CrCbGaD
Lisinopril—ACE2—Metabolism of proteins—TUBA1B—osteoporosis	0.000885	0.0115	CbGpPWpGaD
Lisinopril—Spirapril—ACE—osteoporosis	0.000713	0.11	CrCbGaD
Lisinopril—ACE2—Metabolism of proteins—RPL24—osteoporosis	0.000707	0.00919	CbGpPWpGaD
Lisinopril—Moexipril—ACE—osteoporosis	0.000684	0.105	CrCbGaD
Lisinopril—Benazepril—MTHFR—osteoporosis	0.000678	0.105	CrCbGaD
Lisinopril—Quinapril—ACE—osteoporosis	0.000636	0.098	CrCbGaD
Lisinopril—Cilazapril—ACE—osteoporosis	0.000636	0.098	CrCbGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—PKM—osteoporosis	0.000622	0.00809	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—TLN1—osteoporosis	0.000621	0.00807	CbGpPWpGaD
Lisinopril—Trandolapril—ACE—osteoporosis	0.000615	0.095	CrCbGaD
Lisinopril—Ramipril—ACE—osteoporosis	0.000615	0.095	CrCbGaD
Lisinopril—ACE2—Metabolism of proteins—REN—osteoporosis	0.000597	0.00776	CbGpPWpGaD
Lisinopril—Benazepril—ACE—osteoporosis	0.000553	0.0853	CrCbGaD
Lisinopril—ACE—Peptide hormone metabolism—LEP—osteoporosis	0.000548	0.00712	CbGpPWpGaD
Lisinopril—ABCB1—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000486	0.00631	CbGpPWpGaD
Lisinopril—ACE—Peptide hormone metabolism—POMC—osteoporosis	0.000471	0.00612	CbGpPWpGaD
Lisinopril—Enalapril—ACE—osteoporosis	0.000466	0.072	CrCbGaD
Lisinopril—ACE—Metabolism of proteins—CCT2—osteoporosis	0.000465	0.00604	CbGpPWpGaD
Lisinopril—ACE—Peptide hormone metabolism—IGF1—osteoporosis	0.000453	0.00588	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—TUBA1B—osteoporosis	0.000434	0.00564	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—TUBA1B—osteoporosis	0.000395	0.00513	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—ACE—osteoporosis	0.000373	0.00484	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—RPL24—osteoporosis	0.000316	0.0041	CbGpPWpGaD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000279	0.00363	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—TLN1—osteoporosis	0.000278	0.00361	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—REN—osteoporosis	0.000267	0.00347	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—ENO1—osteoporosis	0.000235	0.00305	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—LEP—osteoporosis	0.000232	0.00301	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000205	0.00267	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—POMC—osteoporosis	0.000199	0.00259	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—IGF1—osteoporosis	0.000191	0.00249	CbGpPWpGaD
Lisinopril—Hypersensitivity—Ibandronate—osteoporosis	0.000136	0.000526	CcSEcCtD
Lisinopril—Cough—Conjugated Estrogens—osteoporosis	0.000136	0.000526	CcSEcCtD
Lisinopril—Dyspnoea—Risedronate—osteoporosis	0.000135	0.000525	CcSEcCtD
Lisinopril—Erythema multiforme—Estradiol—osteoporosis	0.000135	0.000524	CcSEcCtD
Lisinopril—Hypotension—Pamidronate—osteoporosis	0.000135	0.000523	CcSEcCtD
Lisinopril—Dry mouth—Zoledronate—osteoporosis	0.000135	0.000522	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000135	0.000521	CcSEcCtD
Lisinopril—Fatigue—Ethinyl Estradiol—osteoporosis	0.000134	0.000521	CcSEcCtD
Lisinopril—Pruritus—Alendronate—osteoporosis	0.000134	0.000519	CcSEcCtD
Lisinopril—Dyspepsia—Risedronate—osteoporosis	0.000134	0.000518	CcSEcCtD
Lisinopril—Tinnitus—Estradiol—osteoporosis	0.000133	0.000517	CcSEcCtD
Lisinopril—Constipation—Ethinyl Estradiol—osteoporosis	0.000133	0.000516	CcSEcCtD
Lisinopril—Confusional state—Zoledronate—osteoporosis	0.000133	0.000515	CcSEcCtD
Lisinopril—Hypersensitivity—Calcitriol—osteoporosis	0.000133	0.000515	CcSEcCtD
Lisinopril—Flushing—Estradiol—osteoporosis	0.000133	0.000515	CcSEcCtD
Lisinopril—Arthralgia—Conjugated Estrogens—osteoporosis	0.000132	0.000513	CcSEcCtD
Lisinopril—Myalgia—Conjugated Estrogens—osteoporosis	0.000132	0.000513	CcSEcCtD
Lisinopril—Chest pain—Conjugated Estrogens—osteoporosis	0.000132	0.000513	CcSEcCtD
Lisinopril—Asthenia—Ibandronate—osteoporosis	0.000132	0.000513	CcSEcCtD
Lisinopril—Anxiety—Conjugated Estrogens—osteoporosis	0.000132	0.000512	CcSEcCtD
Lisinopril—Nausea—Etidronic acid—osteoporosis	0.000132	0.000511	CcSEcCtD
Lisinopril—Oedema—Zoledronate—osteoporosis	0.000132	0.000511	CcSEcCtD
Lisinopril—Anaphylactic shock—Zoledronate—osteoporosis	0.000132	0.000511	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000132	0.00051	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000132	0.00051	CcSEcCtD
Lisinopril—Diarrhoea—Estropipate—osteoporosis	0.000132	0.00051	CcSEcCtD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoporosis	0.000131	0.00171	CbGpPWpGaD
Lisinopril—Gastrointestinal disorder—Risedronate—osteoporosis	0.000131	0.000508	CcSEcCtD
Lisinopril—Infection—Zoledronate—osteoporosis	0.000131	0.000508	CcSEcCtD
Lisinopril—Fatigue—Risedronate—osteoporosis	0.000131	0.000508	CcSEcCtD
Lisinopril—Insomnia—Pamidronate—osteoporosis	0.000131	0.000506	CcSEcCtD
Lisinopril—Pruritus—Ibandronate—osteoporosis	0.00013	0.000505	CcSEcCtD
Lisinopril—Constipation—Risedronate—osteoporosis	0.00013	0.000503	CcSEcCtD
Lisinopril—Pain—Risedronate—osteoporosis	0.00013	0.000503	CcSEcCtD
Lisinopril—Angiopathy—Estradiol—osteoporosis	0.00013	0.000503	CcSEcCtD
Lisinopril—Shock—Zoledronate—osteoporosis	0.00013	0.000503	CcSEcCtD
Lisinopril—Paraesthesia—Pamidronate—osteoporosis	0.00013	0.000503	CcSEcCtD
Lisinopril—Diarrhoea—Alendronate—osteoporosis	0.00013	0.000502	CcSEcCtD
Lisinopril—Asthenia—Calcitriol—osteoporosis	0.000129	0.000502	CcSEcCtD
Lisinopril—Thrombocytopenia—Zoledronate—osteoporosis	0.000129	0.000501	CcSEcCtD
Lisinopril—Mediastinal disorder—Estradiol—osteoporosis	0.000129	0.0005	CcSEcCtD
Lisinopril—Dyspnoea—Pamidronate—osteoporosis	0.000129	0.000499	CcSEcCtD
Lisinopril—Tachycardia—Zoledronate—osteoporosis	0.000129	0.000499	CcSEcCtD
Lisinopril—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000128	0.000498	CcSEcCtD
Lisinopril—Chills—Estradiol—osteoporosis	0.000128	0.000498	CcSEcCtD
Lisinopril—Somnolence—Pamidronate—osteoporosis	0.000128	0.000498	CcSEcCtD
Lisinopril—Skin disorder—Zoledronate—osteoporosis	0.000128	0.000497	CcSEcCtD
Lisinopril—Pruritus—Calcitriol—osteoporosis	0.000128	0.000495	CcSEcCtD
Lisinopril—Hyperhidrosis—Zoledronate—osteoporosis	0.000128	0.000494	CcSEcCtD
Lisinopril—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000127	0.000494	CcSEcCtD
Lisinopril—Diarrhoea—Raloxifene—osteoporosis	0.000127	0.000494	CcSEcCtD
Lisinopril—Dyspepsia—Pamidronate—osteoporosis	0.000127	0.000493	CcSEcCtD
Lisinopril—Dizziness—Estropipate—osteoporosis	0.000127	0.000493	CcSEcCtD
Lisinopril—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000127	0.000492	CcSEcCtD
Lisinopril—Oedema—Conjugated Estrogens—osteoporosis	0.000127	0.000492	CcSEcCtD
Lisinopril—Alopecia—Estradiol—osteoporosis	0.000126	0.00049	CcSEcCtD
Lisinopril—Infection—Conjugated Estrogens—osteoporosis	0.000126	0.000489	CcSEcCtD
Lisinopril—Diarrhoea—Ibandronate—osteoporosis	0.000126	0.000489	CcSEcCtD
Lisinopril—Anorexia—Zoledronate—osteoporosis	0.000126	0.000487	CcSEcCtD
Lisinopril—Decreased appetite—Pamidronate—osteoporosis	0.000126	0.000486	CcSEcCtD
Lisinopril—Mental disorder—Estradiol—osteoporosis	0.000125	0.000486	CcSEcCtD
Lisinopril—Dizziness—Alendronate—osteoporosis	0.000125	0.000485	CcSEcCtD
Lisinopril—Shock—Conjugated Estrogens—osteoporosis	0.000125	0.000484	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000125	0.000483	CcSEcCtD
Lisinopril—Malnutrition—Estradiol—osteoporosis	0.000125	0.000483	CcSEcCtD
Lisinopril—Erythema—Estradiol—osteoporosis	0.000125	0.000483	CcSEcCtD
Lisinopril—Fatigue—Pamidronate—osteoporosis	0.000124	0.000482	CcSEcCtD
Lisinopril—Gastrointestinal pain—Risedronate—osteoporosis	0.000124	0.000481	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.000124	0.00161	CbGpPWpGaD
Lisinopril—Tachycardia—Conjugated Estrogens—osteoporosis	0.000124	0.00048	CcSEcCtD
Lisinopril—Urticaria—Ethinyl Estradiol—osteoporosis	0.000124	0.00048	CcSEcCtD
Lisinopril—Pain—Pamidronate—osteoporosis	0.000123	0.000479	CcSEcCtD
Lisinopril—Constipation—Pamidronate—osteoporosis	0.000123	0.000479	CcSEcCtD
Lisinopril—Diarrhoea—Calcitriol—osteoporosis	0.000123	0.000478	CcSEcCtD
Lisinopril—Skin disorder—Conjugated Estrogens—osteoporosis	0.000123	0.000478	CcSEcCtD
Lisinopril—Hypotension—Zoledronate—osteoporosis	0.000123	0.000478	CcSEcCtD
Lisinopril—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000123	0.000477	CcSEcCtD
Lisinopril—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000123	0.000477	CcSEcCtD
Lisinopril—Dizziness—Raloxifene—osteoporosis	0.000123	0.000477	CcSEcCtD
Lisinopril—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000123	0.000476	CcSEcCtD
Lisinopril—Flatulence—Estradiol—osteoporosis	0.000123	0.000476	CcSEcCtD
Lisinopril—Tension—Estradiol—osteoporosis	0.000122	0.000474	CcSEcCtD
Lisinopril—Vomiting—Estropipate—osteoporosis	0.000122	0.000474	CcSEcCtD
Lisinopril—Dysgeusia—Estradiol—osteoporosis	0.000122	0.000473	CcSEcCtD
Lisinopril—Dizziness—Ibandronate—osteoporosis	0.000122	0.000472	CcSEcCtD
Lisinopril—Rash—Estropipate—osteoporosis	0.000121	0.00047	CcSEcCtD
Lisinopril—Dermatitis—Estropipate—osteoporosis	0.000121	0.000469	CcSEcCtD
Lisinopril—Anorexia—Conjugated Estrogens—osteoporosis	0.000121	0.000469	CcSEcCtD
Lisinopril—Nervousness—Estradiol—osteoporosis	0.000121	0.000469	CcSEcCtD
Lisinopril—Urticaria—Risedronate—osteoporosis	0.000121	0.000468	CcSEcCtD
Lisinopril—Back pain—Estradiol—osteoporosis	0.00012	0.000467	CcSEcCtD
Lisinopril—Headache—Estropipate—osteoporosis	0.00012	0.000467	CcSEcCtD
Lisinopril—Vomiting—Alendronate—osteoporosis	0.00012	0.000466	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00012	0.000466	CcSEcCtD
Lisinopril—Abdominal pain—Risedronate—osteoporosis	0.00012	0.000465	CcSEcCtD
Lisinopril—Body temperature increased—Risedronate—osteoporosis	0.00012	0.000465	CcSEcCtD
Lisinopril—Muscle spasms—Estradiol—osteoporosis	0.00012	0.000464	CcSEcCtD
Lisinopril—Rash—Alendronate—osteoporosis	0.000119	0.000463	CcSEcCtD
Lisinopril—Insomnia—Zoledronate—osteoporosis	0.000119	0.000462	CcSEcCtD
Lisinopril—Dermatitis—Alendronate—osteoporosis	0.000119	0.000462	CcSEcCtD
Lisinopril—Feeling abnormal—Pamidronate—osteoporosis	0.000119	0.000461	CcSEcCtD
Lisinopril—Hypotension—Conjugated Estrogens—osteoporosis	0.000119	0.00046	CcSEcCtD
Lisinopril—Headache—Alendronate—osteoporosis	0.000119	0.00046	CcSEcCtD
Lisinopril—Paraesthesia—Zoledronate—osteoporosis	0.000118	0.000459	CcSEcCtD
Lisinopril—Vomiting—Raloxifene—osteoporosis	0.000118	0.000459	CcSEcCtD
Lisinopril—Gastrointestinal pain—Pamidronate—osteoporosis	0.000118	0.000458	CcSEcCtD
Lisinopril—Dyspnoea—Zoledronate—osteoporosis	0.000118	0.000456	CcSEcCtD
Lisinopril—Rash—Raloxifene—osteoporosis	0.000117	0.000455	CcSEcCtD
Lisinopril—Dermatitis—Raloxifene—osteoporosis	0.000117	0.000455	CcSEcCtD
Lisinopril—Somnolence—Zoledronate—osteoporosis	0.000117	0.000454	CcSEcCtD
Lisinopril—Vomiting—Ibandronate—osteoporosis	0.000117	0.000454	CcSEcCtD
Lisinopril—Tremor—Estradiol—osteoporosis	0.000117	0.000452	CcSEcCtD
Lisinopril—Headache—Raloxifene—osteoporosis	0.000117	0.000452	CcSEcCtD
Lisinopril—Rash—Ibandronate—osteoporosis	0.000116	0.00045	CcSEcCtD
Lisinopril—Dermatitis—Ibandronate—osteoporosis	0.000116	0.00045	CcSEcCtD
Lisinopril—Dyspepsia—Zoledronate—osteoporosis	0.000116	0.00045	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000116	0.000448	CcSEcCtD
Lisinopril—Ill-defined disorder—Estradiol—osteoporosis	0.000116	0.000448	CcSEcCtD
Lisinopril—Headache—Ibandronate—osteoporosis	0.000115	0.000448	CcSEcCtD
Lisinopril—Insomnia—Conjugated Estrogens—osteoporosis	0.000115	0.000445	CcSEcCtD
Lisinopril—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000115	0.000445	CcSEcCtD
Lisinopril—Vomiting—Calcitriol—osteoporosis	0.000115	0.000445	CcSEcCtD
Lisinopril—Decreased appetite—Zoledronate—osteoporosis	0.000115	0.000444	CcSEcCtD
Lisinopril—Nausea—Estropipate—osteoporosis	0.000114	0.000442	CcSEcCtD
Lisinopril—Abdominal pain—Pamidronate—osteoporosis	0.000114	0.000442	CcSEcCtD
Lisinopril—Body temperature increased—Pamidronate—osteoporosis	0.000114	0.000442	CcSEcCtD
Lisinopril—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000114	0.000442	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000114	0.000441	CcSEcCtD
Lisinopril—Angioedema—Estradiol—osteoporosis	0.000114	0.000441	CcSEcCtD
Lisinopril—Rash—Calcitriol—osteoporosis	0.000114	0.000441	CcSEcCtD
Lisinopril—Fatigue—Zoledronate—osteoporosis	0.000114	0.000441	CcSEcCtD
Lisinopril—Dermatitis—Calcitriol—osteoporosis	0.000114	0.00044	CcSEcCtD
Lisinopril—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000113	0.000439	CcSEcCtD
Lisinopril—Headache—Calcitriol—osteoporosis	0.000113	0.000438	CcSEcCtD
Lisinopril—Somnolence—Conjugated Estrogens—osteoporosis	0.000113	0.000438	CcSEcCtD
Lisinopril—Pain—Zoledronate—osteoporosis	0.000113	0.000437	CcSEcCtD
Lisinopril—Constipation—Zoledronate—osteoporosis	0.000113	0.000437	CcSEcCtD
Lisinopril—Nausea—Alendronate—osteoporosis	0.000112	0.000436	CcSEcCtD
Lisinopril—Malaise—Estradiol—osteoporosis	0.000112	0.000435	CcSEcCtD
Lisinopril—Hypersensitivity—Risedronate—osteoporosis	0.000112	0.000434	CcSEcCtD
Lisinopril—Vertigo—Estradiol—osteoporosis	0.000112	0.000434	CcSEcCtD
Lisinopril—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000112	0.000433	CcSEcCtD
Lisinopril—Asthenia—Ethinyl Estradiol—osteoporosis	0.000112	0.000433	CcSEcCtD
Lisinopril—Syncope—Estradiol—osteoporosis	0.000112	0.000433	CcSEcCtD
Lisinopril—Nausea—Raloxifene—osteoporosis	0.000111	0.000429	CcSEcCtD
Lisinopril—Decreased appetite—Conjugated Estrogens—osteoporosis	0.00011	0.000428	CcSEcCtD
Lisinopril—Pruritus—Ethinyl Estradiol—osteoporosis	0.00011	0.000427	CcSEcCtD
Lisinopril—Palpitations—Estradiol—osteoporosis	0.00011	0.000427	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.00011	0.000425	CcSEcCtD
Lisinopril—Fatigue—Conjugated Estrogens—osteoporosis	0.00011	0.000424	CcSEcCtD
Lisinopril—Nausea—Ibandronate—osteoporosis	0.000109	0.000424	CcSEcCtD
Lisinopril—Loss of consciousness—Estradiol—osteoporosis	0.000109	0.000424	CcSEcCtD
Lisinopril—Asthenia—Risedronate—osteoporosis	0.000109	0.000422	CcSEcCtD
Lisinopril—Feeling abnormal—Zoledronate—osteoporosis	0.000109	0.000421	CcSEcCtD
Lisinopril—Cough—Estradiol—osteoporosis	0.000109	0.000421	CcSEcCtD
Lisinopril—Pain—Conjugated Estrogens—osteoporosis	0.000109	0.000421	CcSEcCtD
Lisinopril—Constipation—Conjugated Estrogens—osteoporosis	0.000109	0.000421	CcSEcCtD
Lisinopril—Gastrointestinal pain—Zoledronate—osteoporosis	0.000108	0.000418	CcSEcCtD
Lisinopril—Pruritus—Risedronate—osteoporosis	0.000107	0.000417	CcSEcCtD
Lisinopril—Nausea—Calcitriol—osteoporosis	0.000107	0.000415	CcSEcCtD
Lisinopril—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000107	0.000413	CcSEcCtD
Lisinopril—Hypersensitivity—Pamidronate—osteoporosis	0.000106	0.000412	CcSEcCtD
Lisinopril—Chest pain—Estradiol—osteoporosis	0.000106	0.000411	CcSEcCtD
Lisinopril—Arthralgia—Estradiol—osteoporosis	0.000106	0.000411	CcSEcCtD
Lisinopril—Myalgia—Estradiol—osteoporosis	0.000106	0.000411	CcSEcCtD
Lisinopril—Anxiety—Estradiol—osteoporosis	0.000106	0.00041	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000105	0.000408	CcSEcCtD
Lisinopril—Urticaria—Zoledronate—osteoporosis	0.000105	0.000406	CcSEcCtD
Lisinopril—Discomfort—Estradiol—osteoporosis	0.000105	0.000406	CcSEcCtD
Lisinopril—Abdominal pain—Zoledronate—osteoporosis	0.000104	0.000404	CcSEcCtD
Lisinopril—Body temperature increased—Zoledronate—osteoporosis	0.000104	0.000404	CcSEcCtD
Lisinopril—Diarrhoea—Risedronate—osteoporosis	0.000104	0.000403	CcSEcCtD
Lisinopril—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000104	0.000402	CcSEcCtD
Lisinopril—Dry mouth—Estradiol—osteoporosis	0.000104	0.000402	CcSEcCtD
Lisinopril—Asthenia—Pamidronate—osteoporosis	0.000104	0.000402	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—LEP—osteoporosis	0.000103	0.00134	CbGpPWpGaD
Lisinopril—Dizziness—Ethinyl Estradiol—osteoporosis	0.000103	0.000399	CcSEcCtD
Lisinopril—Confusional state—Estradiol—osteoporosis	0.000102	0.000397	CcSEcCtD
Lisinopril—Pruritus—Pamidronate—osteoporosis	0.000102	0.000396	CcSEcCtD
Lisinopril—Anaphylactic shock—Estradiol—osteoporosis	0.000102	0.000394	CcSEcCtD
Lisinopril—Oedema—Estradiol—osteoporosis	0.000102	0.000394	CcSEcCtD
Lisinopril—Infection—Estradiol—osteoporosis	0.000101	0.000391	CcSEcCtD
Lisinopril—Urticaria—Conjugated Estrogens—osteoporosis	0.000101	0.000391	CcSEcCtD
Lisinopril—Dizziness—Risedronate—osteoporosis	0.0001	0.000389	CcSEcCtD
Lisinopril—Abdominal pain—Conjugated Estrogens—osteoporosis	0.0001	0.000389	CcSEcCtD
Lisinopril—Body temperature increased—Conjugated Estrogens—osteoporosis	0.0001	0.000389	CcSEcCtD
Lisinopril—Shock—Estradiol—osteoporosis	0.0001	0.000388	CcSEcCtD
Lisinopril—Tachycardia—Estradiol—osteoporosis	9.92e-05	0.000384	CcSEcCtD
Lisinopril—Vomiting—Ethinyl Estradiol—osteoporosis	9.91e-05	0.000384	CcSEcCtD
Lisinopril—Diarrhoea—Pamidronate—osteoporosis	9.88e-05	0.000383	CcSEcCtD
Lisinopril—Skin disorder—Estradiol—osteoporosis	9.87e-05	0.000383	CcSEcCtD
Lisinopril—Hyperhidrosis—Estradiol—osteoporosis	9.83e-05	0.000381	CcSEcCtD
Lisinopril—Rash—Ethinyl Estradiol—osteoporosis	9.82e-05	0.000381	CcSEcCtD
Lisinopril—Dermatitis—Ethinyl Estradiol—osteoporosis	9.81e-05	0.00038	CcSEcCtD
Lisinopril—Headache—Ethinyl Estradiol—osteoporosis	9.76e-05	0.000378	CcSEcCtD
Lisinopril—Hypersensitivity—Zoledronate—osteoporosis	9.72e-05	0.000377	CcSEcCtD
Lisinopril—Vomiting—Risedronate—osteoporosis	9.66e-05	0.000374	CcSEcCtD
Lisinopril—Rash—Risedronate—osteoporosis	9.58e-05	0.000371	CcSEcCtD
Lisinopril—Dermatitis—Risedronate—osteoporosis	9.57e-05	0.000371	CcSEcCtD
Lisinopril—Dizziness—Pamidronate—osteoporosis	9.55e-05	0.00037	CcSEcCtD
Lisinopril—Headache—Risedronate—osteoporosis	9.52e-05	0.000369	CcSEcCtD
Lisinopril—Asthenia—Zoledronate—osteoporosis	9.46e-05	0.000367	CcSEcCtD
Lisinopril—Hypersensitivity—Conjugated Estrogens—osteoporosis	9.36e-05	0.000363	CcSEcCtD
Lisinopril—Pruritus—Zoledronate—osteoporosis	9.33e-05	0.000362	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Estradiol—osteoporosis	9.26e-05	0.000359	CcSEcCtD
Lisinopril—Nausea—Ethinyl Estradiol—osteoporosis	9.25e-05	0.000359	CcSEcCtD
Lisinopril—Insomnia—Estradiol—osteoporosis	9.19e-05	0.000356	CcSEcCtD
Lisinopril—Vomiting—Pamidronate—osteoporosis	9.18e-05	0.000356	CcSEcCtD
Lisinopril—Paraesthesia—Estradiol—osteoporosis	9.13e-05	0.000354	CcSEcCtD
Lisinopril—Asthenia—Conjugated Estrogens—osteoporosis	9.11e-05	0.000353	CcSEcCtD
Lisinopril—Rash—Pamidronate—osteoporosis	9.1e-05	0.000353	CcSEcCtD
Lisinopril—Dermatitis—Pamidronate—osteoporosis	9.1e-05	0.000353	CcSEcCtD
Lisinopril—Dyspnoea—Estradiol—osteoporosis	9.06e-05	0.000351	CcSEcCtD
Lisinopril—Headache—Pamidronate—osteoporosis	9.05e-05	0.000351	CcSEcCtD
Lisinopril—Somnolence—Estradiol—osteoporosis	9.04e-05	0.00035	CcSEcCtD
Lisinopril—Diarrhoea—Zoledronate—osteoporosis	9.02e-05	0.00035	CcSEcCtD
Lisinopril—Nausea—Risedronate—osteoporosis	9.02e-05	0.00035	CcSEcCtD
Lisinopril—Pruritus—Conjugated Estrogens—osteoporosis	8.99e-05	0.000348	CcSEcCtD
Lisinopril—Dyspepsia—Estradiol—osteoporosis	8.95e-05	0.000347	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—POMC—osteoporosis	8.89e-05	0.00115	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	8.84e-05	0.00115	CbGpPWpGaD
Lisinopril—Decreased appetite—Estradiol—osteoporosis	8.84e-05	0.000342	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Estradiol—osteoporosis	8.78e-05	0.00034	CcSEcCtD
Lisinopril—Fatigue—Estradiol—osteoporosis	8.76e-05	0.00034	CcSEcCtD
Lisinopril—Dizziness—Zoledronate—osteoporosis	8.72e-05	0.000338	CcSEcCtD
Lisinopril—Pain—Estradiol—osteoporosis	8.69e-05	0.000337	CcSEcCtD
Lisinopril—Constipation—Estradiol—osteoporosis	8.69e-05	0.000337	CcSEcCtD
Lisinopril—Diarrhoea—Conjugated Estrogens—osteoporosis	8.69e-05	0.000337	CcSEcCtD
Lisinopril—Nausea—Pamidronate—osteoporosis	8.58e-05	0.000332	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—IGF1—osteoporosis	8.55e-05	0.00111	CbGpPWpGaD
Lisinopril—Dizziness—Conjugated Estrogens—osteoporosis	8.4e-05	0.000325	CcSEcCtD
Lisinopril—Vomiting—Zoledronate—osteoporosis	8.39e-05	0.000325	CcSEcCtD
Lisinopril—Feeling abnormal—Estradiol—osteoporosis	8.38e-05	0.000325	CcSEcCtD
Lisinopril—Rash—Zoledronate—osteoporosis	8.32e-05	0.000322	CcSEcCtD
Lisinopril—Gastrointestinal pain—Estradiol—osteoporosis	8.31e-05	0.000322	CcSEcCtD
Lisinopril—Dermatitis—Zoledronate—osteoporosis	8.31e-05	0.000322	CcSEcCtD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	8.28e-05	0.00108	CbGpPWpGaD
Lisinopril—Headache—Zoledronate—osteoporosis	8.26e-05	0.00032	CcSEcCtD
Lisinopril—Vomiting—Conjugated Estrogens—osteoporosis	8.08e-05	0.000313	CcSEcCtD
Lisinopril—Urticaria—Estradiol—osteoporosis	8.08e-05	0.000313	CcSEcCtD
Lisinopril—Body temperature increased—Estradiol—osteoporosis	8.04e-05	0.000311	CcSEcCtD
Lisinopril—Abdominal pain—Estradiol—osteoporosis	8.04e-05	0.000311	CcSEcCtD
Lisinopril—Rash—Conjugated Estrogens—osteoporosis	8.01e-05	0.00031	CcSEcCtD
Lisinopril—Dermatitis—Conjugated Estrogens—osteoporosis	8e-05	0.00031	CcSEcCtD
Lisinopril—Headache—Conjugated Estrogens—osteoporosis	7.96e-05	0.000308	CcSEcCtD
Lisinopril—Nausea—Zoledronate—osteoporosis	7.83e-05	0.000304	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ADCY5—osteoporosis	7.7e-05	0.001	CbGpPWpGaD
Lisinopril—Nausea—Conjugated Estrogens—osteoporosis	7.54e-05	0.000292	CcSEcCtD
Lisinopril—Hypersensitivity—Estradiol—osteoporosis	7.49e-05	0.00029	CcSEcCtD
Lisinopril—Asthenia—Estradiol—osteoporosis	7.29e-05	0.000283	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—IL1B—osteoporosis	7.25e-05	0.000942	CbGpPWpGaD
Lisinopril—Pruritus—Estradiol—osteoporosis	7.19e-05	0.000279	CcSEcCtD
Lisinopril—Diarrhoea—Estradiol—osteoporosis	6.95e-05	0.00027	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	6.94e-05	0.000902	CbGpPWpGaD
Lisinopril—Dizziness—Estradiol—osteoporosis	6.72e-05	0.000261	CcSEcCtD
Lisinopril—Vomiting—Estradiol—osteoporosis	6.46e-05	0.00025	CcSEcCtD
Lisinopril—Rash—Estradiol—osteoporosis	6.41e-05	0.000248	CcSEcCtD
Lisinopril—Dermatitis—Estradiol—osteoporosis	6.4e-05	0.000248	CcSEcCtD
Lisinopril—Headache—Estradiol—osteoporosis	6.37e-05	0.000247	CcSEcCtD
Lisinopril—Nausea—Estradiol—osteoporosis	6.04e-05	0.000234	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—TGFB1—osteoporosis	5.64e-05	0.000732	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	5.36e-05	0.000696	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—TNF—osteoporosis	5.26e-05	0.000684	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—FDPS—osteoporosis	4.95e-05	0.000643	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PKM—osteoporosis	4.95e-05	0.000643	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GPD2—osteoporosis	4.69e-05	0.000609	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PGLS—osteoporosis	4.69e-05	0.000609	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	4.64e-05	0.000603	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ATIC—osteoporosis	4.29e-05	0.000557	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PNP—osteoporosis	4.29e-05	0.000557	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—OXCT1—osteoporosis	3.65e-05	0.000474	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CA2—osteoporosis	3.65e-05	0.000474	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—MGLL—osteoporosis	3.55e-05	0.000462	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—IDH2—osteoporosis	3.02e-05	0.000393	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP27A1—osteoporosis	2.84e-05	0.000369	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	2.79e-05	0.000362	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	2.78e-05	0.000361	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ACP5—osteoporosis	2.76e-05	0.000359	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.6e-05	0.000338	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	2.6e-05	0.000337	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—TPI1—osteoporosis	2.57e-05	0.000334	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—P4HB—osteoporosis	2.42e-05	0.000314	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GAPDH—osteoporosis	2.37e-05	0.000308	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—RAP1A—osteoporosis	2.31e-05	0.0003	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ENO1—osteoporosis	1.87e-05	0.000243	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PSMA2—osteoporosis	1.84e-05	0.000239	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PSMA5—osteoporosis	1.84e-05	0.000239	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP19A1—osteoporosis	1.49e-05	0.000194	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ADCY5—osteoporosis	1.22e-05	0.000158	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GPX1—osteoporosis	1.22e-05	0.000158	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—MTHFR—osteoporosis	1.12e-05	0.000146	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—POMC—osteoporosis	8.97e-06	0.000117	CbGpPWpGaD
